Finance

Lists
ELAN:NYSE
Elanco Animal Health Inc
US$22,55
+0,62%
(+0,14) 1D
US$22,67
+0,53% (+0,12)
Pre-market
Closed: 14 ຕ.ລ., 16 ໂມງ 0 ນາທີ 05 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Open
US$22,38
High
US$22,92
Low
US$22,26
Mkt. cap
11,27 ຕື້
Avg. vol.
5,31 ລ້ານ
Volume
21,72 ພັນ
52-wk high
US$27,98
52-wk low
US$19,40
EPS
US$-0,42
Beta
1,71
Shares outstanding
499,62 ລ້ານ
No. of employees
10 ພັນ
Open
US$22,38
High
US$22,92
Low
US$22,26
Mkt. cap
11,27 ຕື້
Avg. vol.
5,31 ລ້ານ
Volume
21,72 ພັນ
52-wk high
US$27,98
52-wk low
US$19,40
EPS
US$-0,42
Beta
1,71
Shares outstanding
499,62 ລ້ານ
No. of employees
10 ພັນ
News stories
From web sources and news partners
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9,65 ພັນ
Founded1954
Headquartersອິນເດຍນາໂພລິສ, ອິນເດຍນາ, ສະຫະລັດ
SectorPharmaceutical industry
Websiteelanco.com
Analyst ratings
Based on 12 analysts giving stock ratings to ELAN in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ELAN in the last 3 months.
Highest
Current US$22,55
US$34,00 (+50,78%)
Average
US$31,44 (+39,42%)
Lowest
US$26,00 (+15,30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Clark
Leerink Partners
Buy
Reiterated
US$34,00
+50,8%
10/01/2026
Jonathan Block
Stifel Nicolaus
Buy
Reiterated
-
-
09/18/2026
Steve Scala
TD Cowen
Buy
Reiterated
US$32,00
+41,9%
08/25/2026
Glen Santangelo
Barclays
Buy
Maintained
US$30,00
+33%
08/21/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
US$34,00
+50,8%
08/12/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/12/2026
Chris Schott
J.P. Morgan
Buy
Maintained
-
-
08/11/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
US$26,00
+15,3%
08/10/2026
David Westenberg
Piper Sandler
Buy
Maintained
US$30,00
+33%
08/10/2026
Andrea Alfonso
UBS
Buy
Maintained
US$33,00
+46,3%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
US$34,00
+50,8%
08/06/2026
Scott Schoenhaus
KeyBanc
Buy
Maintained
US$30,00
+33%
08/06/2026
Jasper Hellweg
Argus Research
Buy
Maintained
-
-
06/23/2026
Umer Raffat
Evercore ISI
Buy
Maintained
-
-
05/11/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$30,00
+33%
02/25/2026
Last report
5 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$0,34 / US$0,27
+26,46%beat
Revenue / Est. (USD)
1,37 ຕື້ / 1,31 ຕື້
+4,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
1,14 ຕື້
1,14 ຕື້
1,37 ຕື້
1,37 ຕື້
Cost of goods sold
530,00 ລ້ານ
555,00 ລ້ານ
586,00 ລ້ານ
570,00 ລ້ານ
Cost of revenue
530,00 ລ້ານ
555,00 ລ້ານ
586,00 ລ້ານ
570,00 ລ້ານ
Research and development expenses
89,00 ລ້ານ
93,00 ລ້ານ
97,00 ລ້ານ
92,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
351,00 ລ້ານ
331,00 ລ້ານ
381,00 ລ້ານ
449,00 ລ້ານ
Operating expense
580,00 ລ້ານ
563,00 ລ້ານ
616,00 ລ້ານ
680,00 ລ້ານ
Total operating expenses
1,11 ຕື້
1,12 ຕື້
1,20 ຕື້
1,25 ຕື້
Operating income
27,00 ລ້ານ
26,00 ລ້ານ
169,00 ລ້ານ
118,00 ລ້ານ
Other non operating income
2,00 ລ້ານ
-15,00 ລ້ານ
-8,00 ລ້ານ
-11,00 ລ້ານ
EBT including unusual items
-50,00 ລ້ານ
-259,00 ລ້ານ
87,00 ລ້ານ
56,00 ລ້ານ
EBT excluding unusual items
-25,00 ລ້ານ
-37,00 ລ້ານ
103,00 ລ້ານ
65,00 ລ້ານ
Income tax expense
-16,00 ລ້ານ
17,00 ລ້ານ
30,00 ລ້ານ
2,00 ລ້ານ
Effective tax rate
32,00%
-6,56%
34,48%
3,57%
Other operating expenses
-
-
-
-
Net income
-34,00 ລ້ານ
-276,00 ລ້ານ
57,00 ລ້ານ
54,00 ລ້ານ
Net profit margin
-2,99%
-24,13%
4,16%
3,95%
Earnings per share
0,19
0,13
0,40
0,34
Interest and investment income
-
45,00 ລ້ານ
-
-
Interest expense
-52,00 ລ້ານ
-105,00 ລ້ານ
-57,00 ລ້ານ
-59,00 ລ້ານ
Net interest expenses
-52,00 ລ້ານ
-60,00 ລ້ານ
-57,00 ລ້ານ
-59,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
195,00 ລ້ານ
194,00 ລ້ານ
335,00 ລ້ານ
283,00 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google